218 related articles for article (PubMed ID: 32266532)
41. Spanish-Portuguese consensus statement on use of daylight-mediated photodynamic therapy with methyl aminolevulinate in the treatment of actinic keratosis.
Gilaberte Y; Aguilar M; Almagro M; Correia O; Guillén C; Harto A; Pérez-García B; Pérez-Pérez L; Redondo P; Sánchez-Carpintero I; Serra-Guillén C; Valladares LM
Actas Dermosifiliogr; 2015 Oct; 106(8):623-31. PubMed ID: 26115793
[TBL] [Abstract][Full Text] [Related]
42. Combined daylight and conventional photodynamic therapy with 5-aminolaevulinic acid nanoemulsion (BF-200 ALA) for actinic keratosis of the face and scalp: a new and efficient approach.
Salido-Vallejo R; Jiménez-Nájar F; Garnacho-Sucedo G; Vélez A
Arch Dermatol Res; 2020 Nov; 312(9):675-680. PubMed ID: 31838569
[TBL] [Abstract][Full Text] [Related]
43. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo.
Dirschka T; Radny P; Dominicus R; Mensing H; Brüning H; Jenne L; Karl L; Sebastian M; Oster-Schmidt C; Klövekorn W; Reinhold U; Tanner M; Gröne D; Deichmann M; Simon M; Hübinger F; Hofbauer G; Krähn-Senftleben G; Borrosch F; Reich K; Berking C; Wolf P; Lehmann P; Moers-Carpi M; Hönigsmann H; Wernicke-Panten K; Helwig C; Foguet M; Schmitz B; Lübbert H; Szeimies RM;
Br J Dermatol; 2012 Jan; 166(1):137-46. PubMed ID: 21910711
[TBL] [Abstract][Full Text] [Related]
44. Photodynamic therapy is more effective than imiquimod for actinic keratosis in organ transplant recipients: a randomized intraindividual controlled trial.
Togsverd-Bo K; Halldin C; Sandberg C; Gonzalez H; Wennberg AM; Sørensen SS; Wulf HC; Haedersdal M
Br J Dermatol; 2018 Apr; 178(4):903-909. PubMed ID: 28796885
[TBL] [Abstract][Full Text] [Related]
45. Daylight methyl-aminolevulinate photodynamic therapy versus ingenol mebutate for the treatment of actinic keratoses: an intraindividual comparative analysis.
Genovese G; Fai D; Fai C; Mavilia L; Mercuri SR
Dermatol Ther; 2016 May; 29(3):191-6. PubMed ID: 26799440
[TBL] [Abstract][Full Text] [Related]
46. Daylight-mediated photodynamic therapy of basal cell carcinomas - an explorative study.
Wiegell SR; Skødt V; Wulf HC
J Eur Acad Dermatol Venereol; 2014 Feb; 28(2):169-75. PubMed ID: 23294223
[TBL] [Abstract][Full Text] [Related]
47. Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis.
Dirschka T; Radny P; Dominicus R; Mensing H; Brüning H; Jenne L; Karl L; Sebastian M; Oster-Schmidt C; Klövekorn W; Reinhold U; Tanner M; Gröne D; Deichmann M; Simon M; Hübinger F; Hofbauer G; Krähn-Senftleben G; Borrosch F; Reich K; Berking C; Wolf P; Lehmann P; Moers-Carpi M; Hönigsmann H; Wernicke-Panten K; Hahn S; Pabst G; Voss D; Foguet M; Schmitz B; Lübbert H; Szeimies RM; ;
Br J Dermatol; 2013 Apr; 168(4):825-36. PubMed ID: 23252768
[TBL] [Abstract][Full Text] [Related]
48. Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded study.
Wiegell SR; Haedersdal M; Philipsen PA; Eriksen P; Enk CD; Wulf HC
Br J Dermatol; 2008 Apr; 158(4):740-6. PubMed ID: 18294318
[TBL] [Abstract][Full Text] [Related]
49. Sequential daylight photodynamic therapy and ingenol mebutate versus 2 sessions of daylight photodynamic therapy for the treatment of actinic keratosis: An observational, prospective, comparative study.
Gracia-Cazaña T; Malinis AJG; Almagro-Sánchez M; Linares DP; Gilaberte Y
Photodiagnosis Photodyn Ther; 2019 Sep; 27():34-38. PubMed ID: 31141728
[TBL] [Abstract][Full Text] [Related]
50. Actinic cheilitis: evolution to squamous cell carcinoma after carbon dioxide laser vaporization. A study of 43 cases.
Castiñeiras I; Del Pozo J; Mazaira M; Rodríguez-Lojo R; Fonseca E
J Dermatolog Treat; 2010 Jan; 21(1):49-53. PubMed ID: 19418331
[TBL] [Abstract][Full Text] [Related]
51. Actinic cheilitis treated with one cycle of 5-aminolaevulinic acid-based photodynamic therapy: report of 10 cases.
Sotiriou E; Apalla Z; Koussidou-Erremonti T; Ioannides D
Br J Dermatol; 2008 Jul; 159(1):261-2. PubMed ID: 18489592
[No Abstract] [Full Text] [Related]
52. Efficacy and safety of daylight photodynamic therapy after tailored pretreatment with ablative fractional laser or microdermabrasion: a randomized, side-by-side, single-blind trial in patients with actinic keratosis and large-area field cancerization.
Wenande E; Phothong W; Bay C; Karmisholt KE; Haedersdal M; Togsverd-Bo K
Br J Dermatol; 2019 Apr; 180(4):756-764. PubMed ID: 30117140
[TBL] [Abstract][Full Text] [Related]
53. [Procedure for daylight methyl aminolevulinate photodynamic therapy to treat actinic keratoses].
Girard C; Adamski H; Basset-Séguin N; Beaulieu P; Dreno B; Riboulet JL; Lacour JP
Ann Dermatol Venereol; 2016 Apr; 143(4):257-63. PubMed ID: 27016200
[TBL] [Abstract][Full Text] [Related]
54. Sequential Treatment of Superficial Basal Cell Carcinomas With Topical Methyl Aminolevulinate Photodynamic Therapy and Imiquimod 5% Cream: A Retrospective Study of Clinical and Cosmetic Outcomes.
Logan IT; Kulakov EL; Perrett CM
Dermatol Surg; 2020 Oct; 46(10):1272-1278. PubMed ID: 32011386
[TBL] [Abstract][Full Text] [Related]
55. Treatment of actinic cheilitis with methyl aminolevulinate photodynamic therapy and light fractionation: a prospective study of 10 patients.
Suárez-Pérez JA; López-Navarro N; Herrera-Acosta E; Aguilera J; Gallego E; Bosch R; Herrera E
Eur J Dermatol; 2015; 25(6):623-4. PubMed ID: 26677980
[No Abstract] [Full Text] [Related]
56. Photodynamic therapy for the treatment of actinic cheilitis.
Kodama M; Watanabe D; Akita Y; Tamada Y; Matsumoto Y
Photodermatol Photoimmunol Photomed; 2007 Oct; 23(5):209-10. PubMed ID: 17803601
[TBL] [Abstract][Full Text] [Related]
57. Methyl aminolevulinate daylight photodynamic therapy applied at home for non-hyperkeratotic actinic keratosis of the face or scalp: an open, interventional study conducted in Germany.
Karrer S; Aschoff RAG; Dominicus R; Krähn-Senftleben G; Gauglitz GG; Zarzour A; Kerrouche N; Chavda R; Szeimies RM
J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):661-666. PubMed ID: 30633376
[TBL] [Abstract][Full Text] [Related]
58. Low-level light-assisted photodynamic therapy using a wearable cap-like device for the treatment of actinic keratosis of the scalp.
Fonda-Pascual P; Alegre-Sánchez A; Harto-Castaño A; Moreno-Arrones OM; Pérez-García B; González-Morales ML; Pindado-Ortega C; Gilaberte-Calzada Y; Aguilera J; Jaen-Olasolo P; Fernández-Guarino M
Photodiagnosis Photodyn Ther; 2019 Mar; 25():136-141. PubMed ID: 30508663
[TBL] [Abstract][Full Text] [Related]
59. Intraindividual, right-left comparison of topical 5-aminolevulinic acid photodynamic therapy vs. 5% imiquimod cream for actinic keratoses on the upper extremities.
Sotiriou E; Apalla Z; Maliamani F; Zaparas N; Panagiotidou D; Ioannides D
J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1061-5. PubMed ID: 19470041
[TBL] [Abstract][Full Text] [Related]
60. Simulated-daylight photodynamic therapy with BF-200 aminolaevulinic acid for actinic keratosis: assessment of the efficacy and tolerability in a retrospective study.
Kellner C; Bauriedl S; Hollstein S; Reinhold U
Br J Dermatol; 2015 Apr; 172(4):1146-8. PubMed ID: 25244353
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
